E. Salamon

830 total citations
19 papers, 418 citations indexed

About

E. Salamon is a scholar working on Oncology, Cancer Research and General Health Professions. According to data from OpenAlex, E. Salamon has authored 19 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Cancer Research and 4 papers in General Health Professions. Recurrent topics in E. Salamon's work include Breast Cancer Treatment Studies (6 papers), Estrogen and related hormone effects (4 papers) and Patient-Provider Communication in Healthcare (4 papers). E. Salamon is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Estrogen and related hormone effects (4 papers) and Patient-Provider Communication in Healthcare (4 papers). E. Salamon collaborates with scholars based in Belgium, Switzerland and Germany. E. Salamon's co-authors include D. Huyskens, Vincent Remouchamps, M. Bolla, W.J. Hoogenraad, Laurence Collette, Harry Bartelink, Carla C. Wárlám-Rodenhuis, Walter Van den Bogaert, Sandra Collette and Jean-Claude Horiot and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

E. Salamon

19 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Salamon Belgium 9 170 147 135 128 70 19 418
Marie Larochelle Canada 12 283 1.7× 149 1.0× 229 1.7× 311 2.4× 167 2.4× 16 727
Cristiane Takita United States 18 272 1.6× 184 1.3× 375 2.8× 258 2.0× 151 2.2× 58 876
K. Dyker United Kingdom 17 100 0.6× 167 1.1× 192 1.4× 141 1.1× 234 3.3× 35 738
Alan Rodger Australia 8 126 0.7× 74 0.5× 53 0.4× 282 2.2× 91 1.3× 22 533
Mary Gardner United States 12 246 1.4× 37 0.3× 69 0.5× 124 1.0× 61 0.9× 19 543
Toufic Eid Lebanon 11 131 0.8× 28 0.2× 86 0.6× 279 2.2× 87 1.2× 20 520
Nirav S. Kapadia United States 13 69 0.4× 72 0.5× 89 0.7× 143 1.1× 148 2.1× 45 463
Eric Whitacre United States 10 359 2.1× 128 0.9× 83 0.6× 116 0.9× 42 0.6× 17 543
Wolfgang Gatzemeier Italy 17 454 2.7× 75 0.5× 124 0.9× 300 2.3× 98 1.4× 59 834
Joshua Siglin United States 12 66 0.4× 114 0.8× 91 0.7× 85 0.7× 172 2.5× 19 400

Countries citing papers authored by E. Salamon

Since Specialization
Citations

This map shows the geographic impact of E. Salamon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Salamon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Salamon more than expected).

Fields of papers citing papers by E. Salamon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Salamon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Salamon. The network helps show where E. Salamon may publish in the future.

Co-authorship network of co-authors of E. Salamon

This figure shows the co-authorship network connecting the top 25 collaborators of E. Salamon. A scholar is included among the top collaborators of E. Salamon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Salamon. E. Salamon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Merckaert, Isabelle, Aurore Liénard, Yves Libert, et al.. (2014). Anxiety at the first radiotherapy session for non-metastatic breast cancer: Key communication and communication-related predictors. Radiotherapy and Oncology. 114(1). 35–41. 13 indexed citations
2.
Merckaert, Isabelle, Aurore Liénard, Yves Libert, et al.. (2014). Anxiety and its time courses during radiotherapy for non-metastatic breast cancer: A longitudinal study. Radiotherapy and Oncology. 111(2). 276–280. 33 indexed citations
3.
Merckaert, Isabelle, Aurore Liénard, Yves Libert, et al.. (2014). Anxiety at the First Radiotherapy Session for Non-metastatic Breast Cancer: Key Communication and Communication-Related Predictors. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 151. 2 indexed citations
4.
Merckaert, Isabelle, Aurore Liénard, Yves Libert, et al.. (2013). Is it possible to improve radiotherapy team members’ communication skills? A randomized study assessing the efficacy of a 38-h communication skills training program. Radiotherapy and Oncology. 109(1). 170–177. 34 indexed citations
5.
Collette, Sandra, Laurence Collette, Tom Budiharto, et al.. (2008). Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’. European Journal of Cancer. 44(17). 2587–2599. 157 indexed citations
6.
Huyskens, D., P. Maingon, L. Vanuytsel, et al.. (2008). A qualitative and a quantitative analysis of an auto-segmentation module for prostate cancer. Radiotherapy and Oncology. 90(3). 337–345. 58 indexed citations
7.
Remouchamps, Vincent, et al.. (2007). The use of magnetic sensors to monitor moderate deep inspiration breath hold during breast irradiation with dynamic MLC compensators. Radiotherapy and Oncology. 82(3). 341–348. 40 indexed citations
8.
Remouchamps, Vincent, et al.. (2005). Breathing Curve Produced by Magnetic Sensors: Development and Testing. International Journal of Radiation Oncology*Biology*Physics. 63. S31–S32. 1 indexed citations
9.
Schmidt, Hendrik, et al.. (2003). Efficacy of Meloxicam (Metacam®) as Adjunct to a Basic Therapy for the Treatment of Diarrhoea in Calves. Acta veterinaria Scandinavica. 44(S1). 5 indexed citations
10.
Focan, C., M. Beauduin, E. Salamon, et al.. (2001). Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial. British Journal of Cancer. 85(1). 1–8. 27 indexed citations
11.
Focan, C., M. Beauduin, E. Salamon, et al.. (1998). P102 Adjuvant high-dose medroxyprogesterone acetate (HD-MPA) for early breast cancer. 13 years update of a multicenter randomized trial. European Journal of Cancer. 34. S40–S40. 2 indexed citations
12.
Grégoire, V., M. Beauduin, Yves Humblet, et al.. (1991). A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: a report from the UCL-Oncology Group, Belgium.. Journal of Clinical Oncology. 9(8). 1385–1392. 15 indexed citations
13.
Focan, C., J. Michel, Martine Piccart, et al.. (1990). Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer. Cancer Chemotherapy and Pharmacology. 26(S1). S63–S65. 8 indexed citations
14.
Focan, C., A Baudoux, M. Beauduin, et al.. (1989). Adjuvant Treatment with High Dose Medroxyprogesterone Acetate in Node-Negative Early Breast Cancer A 3-year Interim Report on a Randomized Trial (I). Acta Oncologica. 28(2). 237–240. 6 indexed citations
15.
Focan, C., A Baudoux, M. Beauduin, et al.. (1987). Improvement of hematological and general tolerance to CMF by high-dose medroxyprogesterone acetate (HD-MPA) adjuvant treatment for primary node positive breast cancer (analysis of 100 patients).. PubMed. 6(5). 1095–9. 6 indexed citations
16.
Focan, C, et al.. (1984). [Efficacy of sequential chemotherapy including vincristine, cisplatin and ifosfamide in the treatment of stage IV head and neck carcinomas and melanomas with visceral involvement. Preliminary results].. PubMed. 71(2). 105–7. 1 indexed citations
17.
Salamon, E., et al.. (1984). [Total body electron therapy of mycosis fungoides].. PubMed. 67(3). 177–82. 2 indexed citations
18.
Focan, C, et al.. (1983). Ifosfamide (with mesna), vincristine and cis-platinum for carcinoma of the head and neck. Cancer Treatment Reviews. 10. 159–161. 7 indexed citations
19.
Dutreix, J, F. Eschwège, André Wambersie, & E. Salamon. (1971). EARLY RECOVERY OF SKIN REACTIONS IN MICE AFTER 15 SESSIONS OF SPLIT-DOSE IRRADIATION.. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie Larochelle Breakdown of academic impact, for papers by Cristiane Takita Breakdown of academic impact, for papers by K. Dyker Breakdown of academic impact, for papers by Alan Rodger Breakdown of academic impact, for papers by Mary Gardner Breakdown of academic impact, for papers by Toufic Eid Breakdown of academic impact, for papers by Nirav S. Kapadia Breakdown of academic impact, for papers by Eric Whitacre Breakdown of academic impact, for papers by Wolfgang Gatzemeier Breakdown of academic impact, for papers by Joshua Siglin
Rankless by CCL
2026